Streetbeat News

Stock Prices

CVNA

KMX

Carvana Co (CVNA) shares declined, influenced by CarMax Inc's (KMX) drop after reporting worse-than-expected earnings. CarMax's Q4 revenue and EPS missed estimates, with a slight decrease in net revenues and used vehicle unit sales. Despite this, CarMax's CEO remains optimistic, aiming for significant sales growth by 2030. Carvana is anticipated to report a Q1 loss but has seen a 90.61% stock increase over three months. Analysts rate Carvana as Neutral, with expectations of a significant rise.

Portfolio Pulse from Adam Eckert

April 11, 2024 | 3:33 pm

NA

Nano Labs shares were halted due to a circuit breaker trigger after the stock plummeted by 20.7%.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 3:31 pm

NA

Nano Labs Ltd (NASDAQ:NA), a fabless integrated circuit design company based in China, announced a $5M registered direct offering at $1.15 per share, including warrants. The offering involves 4,347,825 Class A ordinary shares and warrants for up to 6,521,737 shares, exercisable at $1.265. The proceeds, before fees and expenses, are aimed for company growth. Maxim Group LLC is the placement agent. The offering's closure is anticipated around April 15, 2024, pending customary conditions.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 3:31 pm

ACGL

Arch Capital Group (NYSE:ACGL) has seen a decrease in short interest, now at 2.91 million shares or 0.91% of float, lower than its peer group average of 1.81%. This reduction suggests a more bullish sentiment among investors towards ACGL, contrasting with the general perception that high short interest indicates bearish market sentiment. The current short interest represents a 3.19% decline from the last report, with a short ratio of 1.75 days.

Portfolio Pulse from Benzinga Insights

April 11, 2024 | 3:30 pm

MCD

Over the past 20 years, McDonald's (NYSE:MCD) has produced an average annual return of 12.25%, outperforming the market by 4.33% on an annualized basis. A $100 investment in MCD 20 years ago would be worth $1,000.52 today, showcasing the impact of compounded returns over time. McDonald's current market capitalization stands at $193.74 billion.

Portfolio Pulse from Benzinga Insights

April 11, 2024 | 3:30 pm

AXON

Over the past 5 years, Axon Enterprise (NASDAQ:AXON) has significantly outperformed the market, with an annualized return of 38.88%, turning a $100 investment into $523.42. The company now has a market capitalization of $24.00 billion.

Portfolio Pulse from Benzinga Insights

April 11, 2024 | 3:30 pm

CSCO

Cisco Systems (NYSE:CSCO) has seen a 4.81% increase in short interest, now at 44.28 million shares or 1.09% of float, taking traders 1.97 days to cover. This rise indicates a more bearish market sentiment towards CSCO, though it has less short interest compared to its peers' average of 8.77%. The increase in short interest doesn't necessarily predict a price drop but suggests traders are betting more on a decline.

Portfolio Pulse from Benzinga Insights

April 11, 2024 | 3:30 pm

IBP

Installed Building Prods (NYSE:IBP) has seen a 7.61% increase in short interest since its last report, with 1.12 million shares sold short, representing 5.8% of its float. This requires an average of 3.94 days to cover. The rise in short interest can indicate bearish market sentiment, but it's noted that an increase in short interest doesn't necessarily predict a near-term price drop. Compared to its peers, IBP has a lower short interest percentage of float, with the peer group average at 6.28%.

Portfolio Pulse from Benzinga Insights

April 11, 2024 | 3:30 pm

SWN

Scotiabank analyst Cameron Bean downgraded Southwestern Energy (SWN) from Sector Outperform to Sector Perform while raising the price target from $9 to $9.5.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 3:29 pm

MRK

MRNA

Moderna Inc has paused its plans to build a vaccine manufacturing plant in Kenya due to declining COVID-19 vaccine demand in Africa, leading to over $1 billion in losses and write-downs. The decision reflects a shift in investment strategy away from pandemic preparedness in Africa. Despite this, Moderna shares saw a jump after presenting positive results from a therapy study in collaboration with Merck & Co Inc.

Portfolio Pulse from Vandana Singh

April 11, 2024 | 3:24 pm